Princeton Biopharma Capital Partners appeared to be the VC, which was created in 2010. The company was established in North America in United States. The main office of represented VC is situated in the New York.
The fund is constantly included in less than 2 investment rounds annually. Deals in the range of 1 - 5 millions dollars are the general things for fund. The important activity for fund was in 2016.
Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. Among the most popular fund investment industries, there are Medical Device, Consumer Electronics. Among the most popular portfolio startups of the fund, we may highlight ActiveProtective. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States.
We also calculated 3 valuable employees in our database.
The standard case for the fund is to invest in rounds with 4 partakers. Despite the Princeton Biopharma Capital Partners, startups are often financed by Sacha Levy, Philadelphia College of Osteopathic Medicine, Key Safety Systems. The meaningful sponsors for the fund in investment in the same round are Sacha Levy, Philadelphia College of Osteopathic Medicine, New York Angels.
|Amoi Capital||England, London, United Kingdom|
|Cambria Funds||California, El Segundo, United States|
|CICC Wealth Management||China, Guangdong, Shenzhen|
|Core Capital Partners LLP||England, London, United Kingdom|
|European Medical Cannabis Group||-|
|Eutopia VC||France, Ile-de-France, Paris|
|Huaman Chuangmeng||China, Ningbo, Zhejiang|
|INCapital Ventures||Canada, Ontario, Toronto|
|Industrial Strategy Challenge Fund||-|
|JBV Capital||California, San Francisco, United States|
|Nanxi Venture Capital||China, Guangdong, Shenzhen|
|National Human Genome Research Institute||Bethesda, Maryland, United States|
|OneTen Capital||Buffalo, New York, United States|
|Trinity Capital||California, Los Angeles, United States|
|Yike Zongheng||Beijing, Beijing, China|
|$1M||03 Jan 2018||Allentown, Pennsylvania, United States|
|$2M||22 Nov 2016||Allentown, Pennsylvania, United States|
|$1M||13 May 2016||Pennsylvania, United States|
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.